VCEL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.1

Margin Of Safety %

-20

Put/Call OI Ratio

0.2

EPS Next Q Diff

0.49

EPS Last/This Y

0.19

EPS This/Next Y

0.33

Price

45.03

Target Price

60.57

Analyst Recom

1.25

Performance Q

Upside

-64.3%

Beta

1.06

Ticker: VCEL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	VCEL	47.51	0.38	0.00	554
2026-07-14	VCEL	46.07	0.38	0.00	554
2026-07-15	VCEL	46.75	0.38	0.05	554
2026-07-16	VCEL	47.79	0.37	0.17	565
2026-07-17	VCEL	46.61	0.38	0.08	566
2026-07-20	VCEL	45.85	0.77	1.33	307
2026-07-21	VCEL	46.08	0.77	1.33	307
2026-07-22	VCEL	44.63	0.78	999.99	314
2026-07-23	VCEL	45.04	0.80	999.99	316
2026-07-24	VCEL	45.1	0.81	0.60	319
2026-07-27	VCEL	45.33	0.81	1.00	327
2026-07-28	VCEL	46.68	0.81	1.50	331
2026-07-29	VCEL	46.53	0.83	0.00	333
2026-07-30	VCEL	47.55	0.19	0.33	958
2026-07-31	VCEL	45.97	0.19	0.00	968
2026-08-03	VCEL	45.96	0.19	0.00	967
2026-08-04	VCEL	46.34	0.19	0.00	967
2026-08-05	VCEL	45.31	0.19	999.99	966
2026-08-06	VCEL	44.76	0.19	0.14	970
2026-08-07	VCEL	45.05	0.20	1.50	974
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	VCEL	47.47	-100.0	-	0.45
2026-07-14	VCEL	46.06	-100.0	-	0.45
2026-07-15	VCEL	46.74	-100.0	-	0.45
2026-07-16	VCEL	47.81	-100.0	-	0.45
2026-07-17	VCEL	46.64	-100.0	-	0.45
2026-07-20	VCEL	45.88	-100.0	-	0.45
2026-07-21	VCEL	46.13	-100.0	-	0.45
2026-07-22	VCEL	44.60	-100.0	-	0.45
2026-07-23	VCEL	45.06	-100.0	-	0.45
2026-07-24	VCEL	45.10	-100.0	-	0.45
2026-07-27	VCEL	45.31	-100.0	-	0.45
2026-07-28	VCEL	46.68	-100.0	-	0.45
2026-07-29	VCEL	46.52	-100.0	-	0.45
2026-07-30	VCEL	47.60	-100.0	-	0.45
2026-07-31	VCEL	45.97	-8.0	-	0.51
2026-08-03	VCEL	46.03	-8.0	-	0.51
2026-08-04	VCEL	46.03	-8.0	-	0.51
2026-08-05	VCEL	45.31	-15.0	-	0.55
2026-08-06	VCEL	44.72	-15.0	-	0.55
2026-08-07	VCEL	45.03	-44.0	-	0.52
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	VCEL	-19.26	6.10	9.74
2026-07-14	VCEL	-19.26	6.10	9.74
2026-07-15	VCEL	-19.26	6.10	9.74
2026-07-16	VCEL	-19.26	6.10	9.74
2026-07-17	VCEL	-19.26	6.10	9.74
2026-07-20	VCEL	-19.26	6.31	9.74
2026-07-21	VCEL	-19.26	6.31	9.74
2026-07-22	VCEL	-19.26	6.31	9.74
2026-07-23	VCEL	-19.26	6.31	9.74
2026-07-24	VCEL	-19.26	6.31	9.74
2026-07-27	VCEL	-19.26	6.13	9.12
2026-07-28	VCEL	-19.26	6.13	9.12
2026-07-29	VCEL	-19.26	6.13	9.12
2026-07-30	VCEL	-19.26	6.13	9.12
2026-07-31	VCEL	-19.26	6.13	9.12
2026-08-03	VCEL	-19.69	5.07	9.10
2026-08-04	VCEL	-19.69	5.07	9.10
2026-08-06	VCEL	-20.73	5.07	9.10
2026-08-07	VCEL	-20.73	5.07	9.10
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

0.06

Avg. EPS Est. Next Quarter

0.53

Insider Transactions

-20.73

Institutional Transactions

5.07

Beta

1.06

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

112

Fair Value

35.98

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

28.5

Max Drawdown 5-Year %

-70.5

Target Price

60.57

P/E

97.56

Forward P/E

51.24

PEG

0.84

P/S

7.54

P/B

6.24

P/Free Cash Flow

37.45

EPS

0.46

Average EPS Est. Cur. Y

0.52

EPS Next Y. (Est.)

0.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.91

Relative Volume

0.71

Return on Equity vs Sector %

-20.8

Return on Equity vs Industry %

-4.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.06

EBIT Estimation

◆ VCEL Healthcare

$45.09

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

20/25

Volume

9/15

Valuation

14/20

TP/AR

2/10

Options

7/10

RSI

Range 1M

12.7%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

20/30

Estimates

6/20

Inst/Vol

5/15

Options

5/10

EPS Yr

72.7%

52W%

77%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -16.2% upside

Quality

10/30

Valuation

3/30

Growth

14/25

Stability

8/10

LT Trend

0/5

Upside

-16.2%

Quality

MoS

-20%

VCEL — P/E HistoricalBiotechnology

Vericel Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 398

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

VCEL

Latest News

—

Caricamento notizie per VCEL…

stock quote shares VCEL – Vericel Corporation Stock Price stock today

news today VCEL – Vericel Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch VCEL – Vericel Corporation yahoo finance google finance

stock history VCEL – Vericel Corporation invest stock market

stock prices VCEL premarket after hours

ticker VCEL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VCEL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y